No definition available.
Viral encephalitis, not elsewhere classified/unspecified
AB1_VIRAL_ENCEPHALITIS_NOS
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
730 |
4. Check minimum number of eventsNone |
730 |
5. Include endpointsNone |
730 |
6. Filter based on genotype QC (FinnGen only) |
730 |
Control definitions (FinnGen only)
- Control exclude
- AB1_VIRAL_CNS
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF5
Similar endpoints
↥List of similar endpoints to
Viral encephalitis, not elsewhere classified/unspecified
based on the number of shared cases.
Similar with more cases:
- Viral infections of the central nervous system
- Certain infectious and parasitic diseases
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 6491 | 3070 | 3393 |
| Only index persons | 5729 | 2699 | 3030 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.09 | 0.09 | 0.09 |
| Only index persons | 0.11 | 0.10 | 0.12 |
| Median age at first event (years) | |||
| Whole population | 52.94 | 56.53 | 49.53 |
| Only index persons | 52.07 | 55.63 | 48.89 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 730 | 370 | 360 |
| Unadjusted period prevalence (%) | 0.14 | 0.13 | 0.16 |
| Median age at first event (years) | 56.60 | 53.49 | 59.79 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 668
- Matched controls
- 6678
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
A86
ICD-10 Finland
Unspecified viral encephalitis
+∞
323.0
619
*
TAB00
NOMESCO Finland
Lumbar puncture
20.9
125.1
193
127
AA1AD
NOMESCO Finland
CT of head and brain
5.1
74.5
306
949
A87.9
ICD-10 Finland
Viral meningitis, unspecified
369.5
66.8
66
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
7.2
57.3
152
263
XA800
NOMESCO Finland
Neuropsychological investigation
12.5
55.9
104
97
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
9.9
54.8
116
139
R56.8
ICD-10 Finland
Other and unspecified convulsions
9.6
53.4
115
142
R41.0
ICD-10 Finland
Disorientation, unspecified
12.8
50.8
93
83
G04.9
ICD-10 Finland
Encephalitis, myelitis and encephalomyelitis, unspecified
69.0
50.1
57
9
N03AX14
ATC
levetiracetam; systemic
15.2
47.9
81
60
G40.9
ICD-10 Finland
Epilepsy, unspecified
11.9
44.4
84
80
5AB01
NOMESCO Finland
NA
218.0
40.3
41
*
G05.1*B00.4
ICD-10 Finland
Herpesviral meningoencephalitis
376.7
36.3
36
*
A85.8
ICD-10 Finland
Other specified viral encephalitis
+∞
35.7
34
*
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.8
34.5
170
553
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
14.7
34.2
58
43
N03AF02
ATC
oxcarbazepine; oral
9.7
32.7
68
77
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
15.4
32.5
54
38
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
9.4
31.2
66
77
XF400
NOMESCO Finland
ECG with 12 standard connections
3.4
29.5
167
596
R50.9
ICD-10 Finland
Fever, unspecified
3.6
29.1
152
511
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
4.4
28.2
111
290
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
14.3
28.2
48
36
F05.9
ICD-10 Finland
Delirium, unspecified
11.2
25.7
49
47
XA400
NOMESCO Finland
EEG
26.1
21.9
30
12
N03AG01
ATC
valproic acid; systemic, rectal
4.7
21.8
78
184
R51.80
ICD-10 Finland
Headache
3.0
21.3
142
558
G41.9
ICD-10 Finland
Status epilepticus, unspecified
29.1
21.1
28
10
ZX120
NOMESCO Finland
Intravenous
3.6
20.2
99
311
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
28.1
20.2
27
10
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.2
20.1
113
394
B94.1
ICD-10 Finland
Sequelae of viral encephalitis
+∞
19.9
19
*
N03AX18
ATC
lacosamide; systemic
25.5
19.7
27
11
G03.9
ICD-10 Finland
Meningitis, unspecified
108.3
19.7
21
*
R4120
NOMESCO Finland
Occupational therapy
4.3
19.6
76
194
183
Kela drug reimbursment
Lamotrigin and topiramate
21.6
18.7
27
13
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.7
18.7
141
596
N03AB02
ATC
phenytoin; systemic
14.9
18.2
30
21
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.4
18.1
192
973
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
3.6
17.6
83
252
TPH04
NOMESCO Finland
Cathetrisation of vein
2.4
16.9
164
792
G05.1*A85.0
ICD-10 Finland
Encephalitis, myelitis or encephalomyelitis (in) enteroviral
+∞
16.7
16
*
R4150
NOMESCO Finland
Neuropsychological rehabilitation
20.7
16.5
24
12
N71
ICPC
Meningitis/encephalitis
+∞
15.7
15
*
WX892
NOMESCO Finland
Monitored bed care
3.4
15.3
78
252
A41.9
ICD-10 Finland
Sepsis, unspecified
5.3
15.0
46
92
G05.1
ICD-10 Finland
Encephalitis, myelitis and encephalomyelitis in viral diseases classified elsewhere
+∞
14.6
14
*
A84.8
ICD-10 Finland
Other tick-borne viral encephalitis
+∞
14.6
14
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
14.1
296
1960
A84.9
ICD-10 Finland
Tick-borne viral encephalitis, unspecified
+∞
13.6
13
*
B00.4
ICD-10 Finland
Herpesviral encephalitis
142.8
13.5
14
*
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
15.4
13.2
21
14
N05BA09
ATC
clobazam; oral
17.1
13.0
20
12
N03AF01
ATC
carbamazepine; oral, rectal
4.2
13.0
50
127
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.6
13.0
100
422
J05AB11
ATC
valaciclovir; oral
2.5
12.8
104
453
TKC20
NOMESCO Finland
Catheterisation of bladder
3.1
12.6
72
253
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
13.5
12.5
21
16
G41.0
ICD-10 Finland
Grand mal status epilepticus
47.6
11.9
14
*
5CM18
NOMESCO Finland
NA
30.6
11.7
15
5
R53
ICD-10 Finland
Malaise and fatigue
2.1
11.2
151
827
R47.0
ICD-10 Finland
Dysphasia and aphasia
10.3
11.1
21
21
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
5.4
10.9
32
62
R42
ICD-10 Finland
Dizziness and giddiness
2.0
10.9
150
830
J01DB01
ATC
cefalexin; oral
1.9
10.7
529
4467
R11
ICD-10 Finland
Nausea and vomiting
3.0
10.6
64
231
N05AH04
ATC
quetiapine; oral
2.2
10.5
122
628
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.2
10.3
116
590
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
6.4
10.2
26
42
F05.8
ICD-10 Finland
Other delirium
13.4
10.2
17
13
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
2.9
10.2
62
225
WX730
NOMESCO Finland
Conventional respirator
7.1
10.2
24
35
N03AE01
ATC
clonazepam; systemic
3.4
10.1
48
148
N05BA01
ATC
diazepam; systemic, rectal
2.3
10.0
101
488
G40.21
ICD-10 Finland
Partial epileptic seizure with cloudiness and automatism
20.4
9.8
14
7
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.6
9.7
71
290
N03AX16
ATC
pregabalin; oral
1.9
9.7
154
898
G40
ICD-10 Finland
Epilepsy
13.6
9.7
16
12
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.7
9.6
289
2068
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.3
9.5
92
436
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
2.4
9.5
79
347
R4110
NOMESCO Finland
Physiotherapy
1.8
9.5
179
1110
G02.0*B00.3
ICD-10 Finland
Herpesviral meningitis
+∞
9.4
9
*
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.0
9.3
123
666
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.8
9.1
58
220
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.4
8.8
74
324
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
2.6
8.7
62
250
G04.8
ICD-10 Finland
Other encephalitis, myelitis and encephalomyelitis
27.9
8.5
11
*
G40.89
ICD-10 Finland
Other epilepsy
91.2
8.4
9
*
G09
ICD-10 Finland
Sequelae of inflammatory diseases of central nervous system
91.2
8.4
9
*
G01*A69.2
ICD-10 Finland
Meningitis (in) Lyme disease
91.2
8.4
9
*
H02AB06
ATC
prednisolone; systemic
1.6
8.4
292
2150
F07.1
ICD-10 Finland
Postencephalitic syndrome
+∞
8.3
8
*
A87.8
ICD-10 Finland
Other viral meningitis
+∞
8.3
8
*
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.1
8.3
100
522
N06AX11
ATC
mirtazapine; oral
1.7
8.2
198
1317
N03AX09
ATC
lamotrigine; oral
3.2
8.1
42
139
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
2.8
8.1
51
191
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
7.4
8.0
18
25
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.4
8.0
66
287
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.7
7.9
220
1519
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.2
7.8
40
132
L28
ICPC
Limited function/disability (L)
2.0
7.8
106
581
R1260
NOMESCO Finland
Evaluation of communicative skills
5.7
7.7
21
38
N30.0
ICD-10 Finland
Acute cystitis
2.0
7.7
96
508
C03CA01
ATC
furosemide; systemic
1.7
7.7
185
1224
J01MA12
ATC
levofloxacin; systemic
1.9
7.6
121
699
A69.2
ICD-10 Finland
Lyme disease
3.2
7.6
38
123
A28
ICPC
Limited function/disability NOS
2.0
7.6
101
546
G40.11
ICD-10 Finland
Simple partial epileptic seizure that develops into a complex partial seizure
80.9
7.4
8
*
N06AB10
ATC
escitalopram; oral
1.8
7.4
124
733
N05CF01
ATC
zopiclone; oral
1.6
7.1
202
1396
C07AB07
ATC
bisoprolol; oral
1.6
7.1
279
2095
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
2.2
7.0
66
311
N02AA05
ATC
oxycodone; systemic
2.0
6.9
94
516
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.7
6.8
179
1207
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
5.1
6.8
20
40
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.8
6.8
113
666
R4130
NOMESCO Finland
Speech therapy
4.4
6.8
23
54
N03AX23
ATC
brivaracetam; systemic
40.5
6.8
8
*
G93.4
ICD-10 Finland
Encephalopathy, unspecified
40.5
6.8
8
*
G41.2
ICD-10 Finland
Complex partial status epilepticus
40.5
6.8
8
*
B02.0
ICD-10 Finland
Zoster encephalitis
40.5
6.8
8
*
N06AB04
ATC
citalopram; systemic
1.7
6.8
138
868
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
5.3
6.7
19
37
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
5.6
6.6
18
33
N05AA02
ATC
levomepromazine; systemic
3.2
6.6
33
108
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
4.8
6.4
20
43
G00.9
ICD-10 Finland
Bacterial meningitis, unspecified
70.5
6.4
7
*
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
6.6
6.4
15
23
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.6
6.3
187
1303
JN4BD
NOMESCO Finland
Extensive body CT
2.1
6.3
72
369
G05.1*B02.0
ICD-10 Finland
Zoster encephalitis
+∞
6.3
6
*
F02.89*G40.9
ICD-10 Finland
Dementia in epilepsy
26.9
6.2
8
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.4
6.2
48
205
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
2.3
6.2
56
259
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.0
6.2
81
438
N29
ICPC
Neurological sympt/complt other
4.1
6.1
22
55
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.4
6.1
49
211
A02BC02
ATC
pantoprazole; systemic
1.5
6.1
389
3218
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.8
6.1
105
625
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
194
50
52.48
307.65
1.3
1.3
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
227
120
27.00
302.46
1.6
1.4
mmol/l
3.9
3.8
0.25
211
113
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
163
27
77.44
300.40
1.3
1.1
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
231
136
24.39
293.22
1.7
1.4
mg/l
712.8
450.5
6.75
222
129
(3044290) Cell count panel - Cerebral spinal fluid
213
104
28.51
292.80
1.7
1.5
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
153
32
60.23
269.27
1.3
1.1
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
181
121
19.56
213.34
1.8
1.5
e6/l
599.4
1018.0
0.19
158
99
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
181
121
19.56
213.34
1.8
1.4
e6/l
45.0
11.1
2.98
155
94
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
117
23
60.39
207.28
1.5
1.2
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
115
22
61.86
204.76
1.3
1.3
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
133
49
32.97
200.19
1.6
1.7
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
117
43
32.21
175.72
1.2
1.0
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
86
15
64.86
154.97
1.3
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
86
15
64.86
154.97
1.3
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
85
17
56.46
149.17
1.4
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
93
28
37.92
147.95
1.3
1.2
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
83
17
54.96
144.89
1.4
1.1
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
75
12
69.54
136.88
1.3
1.2
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
103
53
22.46
135.47
1.8
1.8
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
73
17
47.60
123.61
1.4
1.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
94
66
16.20
105.89
1.3
1.1
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
58
11
57.19
102.23
1.3
1.3
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
65
20
35.58
102.13
1.2
1.2
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
182
366
6.29
90.64
2.6
2.4
—
19.5
—
0
17
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
51
10
54.76
89.12
1.4
1.2
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
82
65
14.09
85.92
1.6
1.7
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
47
11
45.60
78.93
1.2
1.0
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
108
152
8.17
74.82
1.3
1.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
54
24
24.22
74.63
1.3
1.3
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
97
136
8.07
67.22
1.9
3.3
umol/l
29.3
33.2
0.65
78
117
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
40
21
20.09
51.32
1.2
1.0
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
340
1577
3.16
50.43
5.7
4.3
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
56
59
10.20
48.30
1.6
1.7
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
53
9
63.33
45.99
1.4
1.2
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
55
64
9.21
44.01
1.2
1.2
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
42
33
13.44
43.78
1.1
1.2
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
33
21
16.41
38.51
1.4
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
77
158
5.33
36.22
1.3
1.3
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
38
36
11.08
35.13
1.3
1.0
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
321
1703
2.58
33.53
3.3
2.1
u/l
209.7
297.0
0.61
308
1607
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
29
19
15.85
33.27
1.3
1.0
miu/ml
1815.8
1444.4
0.62
29
19
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
37
6
64.82
32.34
1.3
1.2
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
37
41
9.45
30.59
1.6
1.1
mg/l
65.7
45.7
0.76
32
32
(3018677) aPTT in Platelet poor plasma by Coagulation assay
201
885
2.75
30.14
2.4
2.1
s
30.1
29.6
0.51
194
858
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
34
8
44.43
27.95
1.4
1.1
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
30
7
44.55
24.74
1.3
1.0
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
47
87
5.71
24.60
1.3
1.1
—
—
—
0
0
(4027681)
30
34
9.16
24.33
1.6
1.2
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
30
8
39.03
24.10
1.3
1.0
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
411
2701
2.19
23.55
8.6
6.1
%
8.7
8.6
0.10
381
2552
(3013826) Glucose [Moles/volume] in Serum or Plasma
479
3353
2.25
23.32
7.2
5.0
mmol/l
6.9
6.7
1.33
458
3116
(3006504) Eosinophils/100 leukocytes in Blood
409
2690
2.18
23.30
8.0
5.9
%
2.4
2.9
3.93
377
2525
(3012095) Magnesium [Moles/volume] in Serum or Plasma
188
897
2.48
23.22
3.8
3.6
mmol/l
0.8
0.8
1.09
171
841
(3003458) Phosphate [Moles/volume] in Serum or Plasma
164
734
2.59
23.18
8.6
6.2
mmol/l
1.0
1.1
1.05
151
679
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
196
958
2.43
22.92
2.1
1.8
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
27
29
9.63
22.76
1.4
1.0
u/l
2.2
1.1
0.51
15
18
(42870588) Differential panel, method unspecified - Blood
319
1920
2.17
22.60
7.3
5.7
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
34
50
7.08
22.24
2.4
1.8
e9/l
1.5
1.3
0.24
21
27
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
27
7
39.99
21.85
1.3
1.0
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
423
2863
2.14
21.83
7.4
5.8
e9/l
0.0
0.0
0.35
366
2484
(3013115) Eosinophils [#/volume] in Blood
432
2949
2.14
21.78
7.7
6.1
e9/l
0.2
0.2
2.50
376
2609
(3022096) Basophils/100 leukocytes in Blood
395
2612
2.12
21.59
8.1
5.9
%
0.6
0.7
1.60
363
2455
(3001604) Monocytes [#/volume] in Blood
420
2848
2.12
21.40
7.4
5.8
e9/l
0.6
0.6
2.28
363
2462
(3002030) Lymphocytes/100 leukocytes in Blood
411
2776
2.10
21.02
8.2
6.0
%
26.6
28.0
1.55
378
2608
(3005719) IgG [Mass/volume] in Serum or Plasma
114
448
2.83
20.66
4.0
2.4
g/l
9.7
10.5
1.28
107
413
(3018010) Neutrophils/100 leukocytes in Blood
406
2743
2.08
20.59
7.7
5.8
%
58.4
57.1
1.33
376
2594
(3019198) Lymphocytes [#/volume] in Blood
425
2933
2.07
20.19
7.7
5.8
e9/l
1.8
2.0
0.88
375
2598
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
30
43
7.23
20.06
1.5
1.7
e6/l
938.4
623.6
1.18
12
15
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
409
2789
2.06
20.01
9.8
7.0
mmol/l
1.2
1.2
0.57
350
2359
(3030467) Casts [#/volume] in Urine by Automated count
269
1578
2.12
19.76
3.8
3.1
e6/l
0.3
0.4
0.86
212
1170
(3000850) Epithelial cells [#/volume] in Urine
220
1198
2.20
19.54
2.9
2.6
e6/l
4.9
5.4
0.20
194
1054
(36304419) Bacteria [Presence] in Urine
263
1539
2.11
19.37
3.6
3.1
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
127
546
2.61
19.25
4.8
4.3
kpa
5.8
5.7
0.64
122
529
(3020779) Urea [Moles/volume] in Serum or Plasma
118
491
2.67
19.09
10.3
7.9
mmol/l
8.0
9.7
2.71
110
467
(3033658) Prothrombin time (PT) actual/Normal
248
1426
2.12
19.08
5.2
3.9
%
87.8
89.7
0.55
237
1396
(3031040) Bacteria [#/volume] in Urine by Automated count
509
3799
2.12
19.03
6.2
4.4
e6/l
5587.2
2838.1
—
9
66
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
425
2978
2.02
18.82
7.1
6.3
umol/l
10.1
11.6
3.54
402
2817
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
324
2069
2.02
18.62
4.4
3.2
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
125
543
2.57
18.50
4.9
4.3
mmol/l
1.6
1.7
0.06
108
423
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
43
95
4.75
18.44
1.3
1.6
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
377
2547
1.99
18.37
9.6
6.3
mmol/l
1.2
1.2
0.65
348
2309
(3032080) INR in Blood by Coagulation assay
348
2292
1.99
18.19
10.2
9.6
inr
1.2
1.3
0.12
90
688
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
141
667
2.38
17.29
2.0
1.8
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
277
1712
2.00
17.11
3.9
3.0
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
31
56
5.74
16.61
1.3
1.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
65
209
3.32
16.59
2.2
1.7
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
354
2402
1.92
16.42
6.3
4.9
g/l
34.3
35.6
4.37
332
2249
(3026782) Osmolality of Urine
204
1148
2.08
16.20
3.2
2.7
mosm/kgh2o
525.5
560.0
1.39
176
976
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
139
674
2.31
16.03
2.1
1.8
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
197
1106
2.07
15.68
1.8
1.9
—
—
—
0
0
(3000991) Gas panel - Venous blood
110
488
2.48
15.45
7.9
8.5
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
24
36
6.86
15.38
2.8
1.9
%
11.9
11.7
0.02
17
21
(3020630) Protein [Mass/volume] in Serum or Plasma
101
432
2.55
15.32
3.6
2.9
g/l
65.8
66.7
0.43
88
396
(3002582) Erythrocytes [#/volume] in Urine
274
1751
1.90
14.88
4.1
3.2
e6/l
32.3
85.2
0.75
218
1333
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
19
6
32.45
14.86
1.8
1.2
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
442
3304
1.86
14.40
11.5
9.3
e9/l
4.5
4.1
2.14
388
2901
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
57
189
3.19
13.83
1.9
3.0
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
303
2039
1.83
13.70
4.7
3.8
e6/l
50.8
89.1
1.03
232
1435
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
76
301
2.70
13.41
4.8
4.8
mmol/l
24.1
23.9
0.17
70
272
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
50
157
3.35
13.25
1.6
1.6
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
17
6
28.95
13.00
1.0
1.0
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
22
36
6.27
12.99
3.1
2.0
—
—
—
0
0
(4198724)
17
21
8.26
12.80
1.1
1.8
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
318
2208
1.78
12.69
5.5
3.7
ng/l
31.3
41.3
1.25
236
1513
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
41
117
3.65
12.56
1.5
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
41
117
3.65
12.56
1.5
1.4
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
21
35
6.15
12.18
1.0
1.0
ng/l
345.9
292.0
0.25
14
23
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
21
35
6.15
12.18
1.0
1.0
ng/l
45.0
40.0
0.15
14
22
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
21
35
6.15
12.18
1.0
1.0
ng/l
694.2
590.8
0.35
12
24
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
27
58
4.80
11.97
1.2
1.2
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
178
1052
1.92
11.84
1.9
1.7
nmol/l
1161.7
1179.6
0.09
138
796
(3037467) Urinalysis macro (dipstick) panel - Urine
498
3989
1.78
11.60
6.1
4.2
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
35
95
3.82
11.52
1.4
1.4
mmol/l
82.6
62.9
1.44
28
82
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
82
364
2.41
11.41
1.7
1.4
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
55
202
2.86
11.18
2.6
1.4
g/l
1.1
1.2
0.95
50
196
(40758558) Short blood count panel - Blood
223
1439
1.79
11.11
7.3
6.7
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
89
416
2.30
11.01
1.9
1.6
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
164
965
1.90
10.97
3.2
2.8
e6/l
1.4
1.0
0.92
97
532
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
533
4388
1.80
10.93
9.8
7.4
u/l
77.1
79.0
0.46
506
4108
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
14
5
28.50
10.75
1.1
1.0
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
15
7
21.84
10.71
1.5
3.4
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
15
7
21.84
10.71
1.5
1.0
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
269
1865
1.70
10.23
3.9
3.4
mmol/l
2.3
2.3
1.49
231
1642
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
34
99
3.55
10.13
1.2
1.1
—
13.0
—
0
9
(3028707) Methadone [Presence] in Urine by Screen method
36
109
3.42
10.11
2.1
2.3
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
79
367
2.29
9.90
2.2
1.6
g/l
1.2
1.5
0.58
70
340
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
41
137
3.11
9.84
1.5
1.6
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
140
811
1.90
9.73
3.1
2.4
g/l
2.2
2.3
0.76
124
752
(3017143) Hepatitis C virus Ab [Presence] in Serum
124
693
1.95
9.59
1.8
1.6
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
101
526
2.07
9.51
2.8
2.4
u/l
30.0
32.3
0.28
83
453
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
112
616
1.97
9.05
4.5
4.1
u/l
232.2
236.5
0.19
107
580
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
39
134
3.02
8.94
1.5
1.6
—
—
—
0
0
(3018418) pH of Serum or Plasma
241
1672
1.66
8.89
6.4
4.0
ph
7.4
7.4
0.20
50
310
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
12
15
8.12
8.88
1.2
1.3
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
13
18
7.34
8.87
1.0
1.3
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
252
1771
1.65
8.82
2.9
2.5
u/l
56.7
56.3
0.05
233
1645
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
268
1916
1.63
8.75
3.6
3.3
u/l
34.0
32.3
0.21
252
1829
(3024928) Oxygen saturation in Venous blood
37
125
3.06
8.74
5.1
5.3
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
62
274
2.38
8.71
5.4
3.6
%
0.7
0.6
0.80
62
265
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
74
353
2.22
8.70
1.7
1.6
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
257
1820
1.64
8.70
3.2
2.3
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
15
25
6.10
8.68
2.3
2.4
umol/l
60.9
47.0
0.81
15
20
(3037522) Nuclear Ab [Titer] in Serum
128
746
1.87
8.67
1.5
1.3
titre
508.2
507.1
0.00
34
158
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
13
8
16.52
8.57
1.5
1.4
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
75
365
2.18
8.40
3.3
2.6
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
23
58
4.06
8.39
1.3
1.3
g/l
0.3
0.4
0.74
15
43
(3028192) IgG subclass 2 [Mass/volume] in Serum
23
58
4.06
8.39
1.3
1.3
g/l
2.1
2.9
1.13
15
43
(3027135) IgG subclass 1 [Mass/volume] in Serum
23
58
4.06
8.39
1.3
1.3
g/l
5.1
7.1
2.49
15
44
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
129
762
1.84
8.36
3.3
2.5
%
21.0
22.9
0.94
106
662
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
13
9
14.68
8.22
1.1
1.0
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
24
64
3.84
8.12
1.4
1.5
mosm/kgh2o
273.5
279.7
0.53
18
41
(4062490)
23
60
3.93
8.02
1.3
1.3
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
236
1665
1.62
7.98
3.2
3.1
ng/l
1416.7
1410.2
0.01
195
1419
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
38
138
2.85
7.92
1.4
1.2
u/ml
24.3
2.8
—
6
15
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
38
139
2.83
7.82
1.4
1.2
u/ml
10.1
13.2
—
6
24
(3021589) Normoblasts [#/volume] in Blood
334
2565
1.56
7.80
13.8
9.5
e9/l
0.0
0.0
0.01
268
2093
(1616796) Gas panel - Central venous blood
35
124
2.91
7.63
5.3
3.6
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
11
6
18.58
7.62
2.3
6.3
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
32
109
3.02
7.47
1.6
1.4
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
27
83
3.34
7.45
1.4
1.6
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
301
2276
1.55
7.44
2.3
2.0
pmol/l
90.7
94.0
0.61
165
1201
(3022948) Iron [Moles/volume] in Serum or Plasma
140
879
1.73
7.34
3.2
2.4
umol/l
11.6
13.1
1.97
123
810
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
30
100
3.09
7.27
1.4
1.7
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
466
3891
1.55
7.20
4.0
3.1
u/l
55.8
47.2
1.12
431
3646
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
61
291
2.20
7.19
9.0
10.3
mmol/l
23.9
24.4
0.42
56
272
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
50
220
2.37
7.11
2.2
2.0
ug/l
0.7
3.0
1.01
43
191
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
75
390
2.03
7.07
4.6
4.1
mmol/l
1.7
1.6
0.16
52
296
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
18
43
4.27
7.04
1.3
1.7
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
54
247
2.28
7.03
1.5
2.0
g/l
1.8
1.5
1.05
46
219
(3012501) Base excess in Blood by calculation
34
125
2.80
6.95
6.5
4.0
mmol/l
2.9
2.6
0.25
24
79
(3009343) pH of Capillary blood
77
408
1.99
6.89
4.6
4.0
ph
7.4
7.4
0.55
11
45
(3024980) IgG subclass 4 [Mass/volume] in Serum
29
98
3.04
6.88
1.3
1.6
g/l
0.5
0.8
1.27
21
79
(3027945) Reticulocytes/100 erythrocytes in Blood
109
650
1.80
6.80
3.7
2.8
%
1.9
1.8
0.40
96
587
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
40
162
2.55
6.79
2.7
2.7
u/ml
0.4
0.3
0.79
22
82
(3003396) Base excess in Arterial blood by calculation
108
644
1.79
6.73
8.3
8.4
mmol/l
0.3
1.1
0.80
88
506
(3001964) Herpes simplex virus Ag [Presence] in Specimen
10
14
7.23
6.71
1.4
1.3
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
44
188
2.43
6.68
3.2
1.9
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
173
1177
1.62
6.62
1.8
1.4
g/l
2.2
2.4
0.91
113
723
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
77
414
1.96
6.61
4.7
4.0
kpa
5.1
5.1
0.02
70
384
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
22
64
3.51
6.61
1.4
1.6
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
93
534
1.85
6.55
2.3
2.5
g/l
0.2
0.2
0.27
85
502
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
29
101
2.95
6.54
4.3
3.2
%
52.7
57.6
0.96
29
101
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
143
930
1.67
6.54
3.6
3.0
e6/l
4.1
2.2
0.74
79
499
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
109
659
1.77
6.48
3.0
2.9
umol/l
9.1
8.6
0.07
90
580
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
24
75
3.27
6.47
1.3
1.6
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
107
647
1.77
6.36
8.1
8.3
kpa
5.1
5.1
0.04
100
619
(3027801) Oxygen [Partial pressure] in Arterial blood
107
647
1.77
6.36
8.1
8.3
kpa
12.7
12.2
0.37
100
622
(3019832) Treponema pallidum Ab [Presence] in Serum
99
586
1.80
6.32
1.4
1.7
—
—
—
0
0
(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
6
0
+∞
6.26
1.2
0.0
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
202
1449
1.54
6.10
2.2
2.1
mg/l
2.9
3.1
0.30
169
1239
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
161
1097
1.60
6.08
4.1
3.7
ng/l
87.8
310.6
2.77
124
843
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
25
84
3.05
6.01
1.4
1.6
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
492
4235
1.50
5.96
5.3
4.0
mm/h
13.9
11.7
2.01
460
3895
(3022217) INR in Platelet poor plasma by Coagulation assay
113
709
1.70
5.88
26.8
23.0
inr
1.3
1.3
0.01
11
95
(3021879) Hepatitis B virus core Ab [Presence] in Serum
79
446
1.86
5.87
1.4
1.4
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
150
1013
1.61
5.86
3.4
3.1
mmol/l
2.5
2.4
0.25
127
898
(40760888) Immunoglobulin light chains.free panel - Serum
31
120
2.65
5.78
4.3
4.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
26
92
2.89
5.73
1.0
1.1
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
24
82
2.99
5.62
1.8
3.0
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
33
134
2.53
5.61
1.7
1.5
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
38
165
2.37
5.61
4.8
3.9
mg/l
62.5
96.7
0.35
30
130
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
38
165
2.37
5.61
4.8
3.9
mg/l
28.8
31.7
0.15
30
130
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
12
25
4.86
5.51
1.3
1.8
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
81
471
1.81
5.48
4.1
2.8
e9/l
70.6
70.2
0.03
61
368
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
29
112
2.66
5.45
1.4
1.2
—
1.0
—
0
6
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
37
161
2.37
5.44
4.8
3.8
ratio
3.3
2.0
—
5
20
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
31
124
2.57
5.44
1.1
1.3
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
22
73
3.08
5.41
11.1
9.4
mmol/l
8.0
6.8
0.82
17
59
(3019225) pH of Specimen
88
529
1.75
5.33
6.1
4.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
136
917
1.59
5.32
1.8
1.6
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
12
26
4.68
5.27
1.3
1.8
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
17
49
3.53
5.20
1.2
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
17
49
3.53
5.20
1.2
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
17
49
3.53
5.20
1.2
1.1
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
38
171
2.29
5.19
4.3
2.1
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
48
238
2.09
5.17
1.6
2.2
u/l
29.7
39.1
3.46
40
214
(3026493) Urate [Moles/volume] in Serum or Plasma
195
1434
1.49
5.13
3.5
2.7
umol/l
2674.2
6758.1
0.88
172
1240
(3010421) pH of Blood
35
153
2.35
5.11
6.7
3.7
ph
7.4
7.4
0.99
35
123
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
30
122
2.52
5.10
1.3
1.3
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
8
6
13.46
5.09
1.0
1.0
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
30
123
2.50
5.02
1.2
1.3
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
42
201
2.16
4.96
1.3
1.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
61
335
1.90
4.95
1.3
1.2
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
13
32
4.12
4.91
1.2
1.7
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
12
28
4.34
4.84
1.1
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
12
28
4.34
4.84
1.1
1.0
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
21
73
2.93
4.80
1.2
1.6
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
187
1381
1.48
4.78
2.8
2.3
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
25
96
2.66
4.77
1.1
1.1
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
34
152
2.30
4.73
1.4
2.3
mg/l
12.1
11.9
0.03
29
139
(3016879) Cocaine [Presence] in Urine
45
226
2.06
4.71
3.5
1.8
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
36
166
2.23
4.67
1.5
1.3
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
106
694
1.62
4.67
1.9
1.6
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
16
48
3.39
4.62
1.3
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
16
48
3.39
4.62
1.3
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
16
48
3.39
4.62
1.3
1.1
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
180
1328
1.47
4.60
1.7
1.5
nmol/l
21.4
20.7
0.25
158
1130
(3011288) Drugs identified in Urine by Screen method
35
162
2.22
4.50
3.2
2.6
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
71
422
1.76
4.48
4.6
3.9
ng/l
91.3
82.4
0.29
55
381
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
18
60
3.05
4.42
2.9
2.9
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
18
60
3.05
4.42
1.2
1.3
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
20
71
2.87
4.42
2.6
1.7
%
90.6
90.1
0.19
20
71
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
109
728
1.58
4.42
1.8
1.8
%
1.7
1.5
1.20
91
642
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
174
1285
1.46
4.41
2.0
1.7
mg/l
0.8
1.2
2.73
138
979
(3051611) Lipemic interference index of Serum or Plasma
17
55
3.14
4.38
4.5
3.6
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
28
119
2.41
4.37
1.2
1.3
u/ml
411.8
270.1
0.66
20
67
(3009261) Glucose [Presence] in Urine by Test strip
344
2868
1.38
4.35
5.2
3.6
estimate
0.0
0.0
0.50
73
528
(3035350) Ketones [Presence] in Urine by Test strip
339
2822
1.38
4.31
5.0
3.5
estimate
0.0
0.0
0.00
80
548
(3000764) Benzodiazepines [Presence] in Urine
46
241
1.97
4.31
3.5
1.8
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
12
31
3.92
4.27
1.1
1.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
46
242
1.96
4.26
3.5
1.8
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
46
243
1.95
4.21
3.6
1.8
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
44
229
1.98
4.20
2.0
1.8
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
9
13
6.99
4.17
3.9
1.7
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
36
175
2.11
4.13
1.8
1.5
iu/ml
0.0
0.0
—
6
36
(3021440) Promyelocytes/100 leukocytes in Blood
71
433
1.71
4.11
5.6
4.8
%
0.0
0.1
1.35
32
137
(3024891) Influenza virus A+B Ag [Presence] in Specimen
34
162
2.15
4.10
1.3
1.2
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
303
2494
1.37
4.07
3.1
2.8
ug/l
131.5
124.0
0.25
276
2307
(3002179) Metamyelocytes/100 leukocytes in Blood
69
419
1.71
4.06
5.1
4.5
%
0.5
0.4
0.35
27
112
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
38
191
2.04
4.00
3.6
2.5
g/l
10.0
10.6
0.26
30
167
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
78
492
1.66
3.98
2.7
2.5
ug/l
4.7
7.4
1.42
64
436
(3017181) Myelocytes/100 leukocytes in Blood
74
461
1.67
3.96
5.7
4.7
%
1.0
0.8
0.22
34
151
(3026389) Candida sp identified in Specimen by Organism specific culture
19
70
2.76
3.94
1.4
1.3
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
159
2086
0.70
3.94
2.7
2.8
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
68
415
1.70
3.93
5.5
4.8
%
0.1
0.1
0.16
29
119
(3044941) Cell count panel - Synovial fluid
21
82
2.61
3.91
1.5
1.5
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
18
65
2.81
3.88
2.3
2.6
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
119
838
1.50
3.79
2.2
2.0
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
27
121
2.28
3.78
3.8
2.4
%
15.6
15.7
0.06
13
66
(3051651) Icteric interference index of Serum or Plasma
13
39
3.38
3.77
4.3
3.7
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
6
5
12.08
3.77
1.0
3.4
—
—
—
0
0
(3020891) Body temperature
41
219
1.92
3.66
9.7
4.5
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
16
56
2.90
3.64
1.6
1.4
%
61.1
61.5
—
10
42
(3017732) Neutrophils [#/volume] in Blood
63
385
1.70
3.64
4.1
2.8
e9/l
4.5
4.0
0.73
50
300
(3021601) Nitrite [Presence] in Urine by Test strip
335
2836
1.33
3.62
6.9
4.8
estimate
0.0
0.0
0.00
79
547
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
55
324
1.75
3.61
2.5
3.2
pmol/l
4.1
4.6
3.13
48
287
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
71
449
1.64
3.60
9.7
3.8
mmol/l
1.2
1.2
0.11
64
392
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
317
2665
1.33
3.58
5.0
4.0
—
—
—
0
0
(40761535) Cells panel - Urine sediment
72
458
1.63
3.57
4.8
3.4
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
44
243
1.86
3.56
3.7
1.6
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
7
9
7.84
3.56
2.4
1.8
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
24
105
2.33
3.56
6.4
4.9
%
62.6
61.9
0.04
24
105
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
39
207
1.93
3.56
3.5
2.4
g/l
4.3
3.8
0.32
25
151
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
39
207
1.93
3.56
3.5
2.4
g/l
7.1
7.3
0.25
26
161
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
39
207
1.93
3.56
3.5
2.4
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
36
186
1.98
3.54
3.1
2.4
%
99.1
88.6
1.88
36
175
(40768797) Stomach Pathology biopsy report
108
759
1.50
3.48
1.2
1.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
27
534
0.49
3.46
1.4
1.7
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
277
2298
1.33
3.38
2.8
2.3
nmol/l
76.2
76.0
0.03
250
2051
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
29
141
2.10
3.36
1.8
1.7
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
621
5817
1.45
3.22
27.5
14.1
mg/l
24.9
23.9
0.31
560
4608
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
10
28
3.61
3.20
1.5
1.7
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
10
28
3.61
3.20
1.5
1.7
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
10
28
3.61
3.20
1.5
1.7
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
10
28
3.61
3.20
1.5
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
15
55
2.76
3.17
1.5
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
15
55
2.76
3.17
1.5
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
15
55
2.76
3.17
1.5
1.7
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
218
1761
1.34
3.15
4.1
3.2
mmol/l
7.2
7.8
1.17
196
1483
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
85
583
1.52
3.08
5.1
3.4
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
25
119
2.14
3.07
1.6
1.6
e6/l
10793.8
13135.0
0.13
19
89
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
32
168
1.95
3.04
2.9
2.5
%
206.9
179.5
0.82
32
162
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
7
12
5.88
3.02
4.9
1.8
—
—
—
0
0
(3022313) Gas panel - Capillary blood
50
303
1.70
3.01
5.0
4.1
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
15
57
2.67
2.98
1.1
1.1
—
—
—
0
0
(3034426) Prothrombin time (PT)
8
17
4.75
2.92
1.0
1.5
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
152
1174
1.37
2.92
1.7
1.7
pmol/l
435.5
26982928.4
1.17
126
971
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
20
89
2.28
2.89
1.2
1.2
u/ml
6.7
6.4
0.03
11
41
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
27
136
2.02
2.89
1.4
1.4
—
—
—
0
0
(4024509)
12
41
2.96
2.87
1.8
1.2
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
28
145
1.97
2.78
1.4
1.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
198
1603
1.32
2.78
3.6
3.2
mg/l
356.6
226.0
0.18
138
1043
(3052851) Hemolysis interference index of Serum or Plasma
31
167
1.89
2.76
5.0
3.3
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
73
498
1.52
2.73
4.7
3.5
—
—
—
0
0
(4035726)
69
465
1.53
2.73
1.3
1.4
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
19
85
2.27
2.72
1.6
1.6
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
31
168
1.88
2.71
4.0
2.6
g/l
36.8
37.6
0.18
24
145
(4211845)
9
24
3.78
2.68
5.4
3.0
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
31
169
1.87
2.67
1.2
1.4
ug/g
316.5
301.9
0.13
16
101
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
13
49
2.68
2.63
1.1
1.0
—
—
—
0
0
(4306422)
18
80
2.28
2.62
1.0
1.2
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
11
38
2.92
2.59
1.5
2.4
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
9
25
3.63
2.58
1.8
2.9
—
73802.2
—
0
6
(3006462) Nitrate [Presence] in Urine
8
20
4.03
2.57
5.8
3.4
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
35
201
1.78
2.57
1.4
1.3
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
12
44
2.76
2.55
1.2
1.5
promille
1.8
1.3
—
7
33
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
32
179
1.82
2.55
4.4
2.7
g/l
2.0
0.9
0.55
25
161
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
34
194
1.79
2.55
3.9
2.5
g/l
3.4
3.1
0.45
25
156
(3017817) Protein [Mass] in Urine collected for unspecified duration
13
50
2.63
2.54
4.9
2.4
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
25
129
1.97
2.53
1.2
1.2
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
474
4325
1.27
2.49
4.5
3.8
pmol/l
14.9
14.8
0.27
435
3904
(3037121) Protein [Mass/volume] in Urine
35
203
1.76
2.49
5.2
4.1
g/l
0.7
0.2
0.79
21
89
(3006184) Hemoglobin [Mass/volume] in Capillary blood
24
124
1.97
2.43
3.2
2.2
g/l
128.6
128.1
0.04
17
98
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
11
40
2.78
2.38
1.0
1.1
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
23
118
1.98
2.37
1.1
1.2
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
8
22
3.66
2.37
1.0
1.0
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
9
28
3.24
2.31
3.0
2.3
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
19
364
0.51
2.28
1.3
1.4
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
20
99
2.05
2.28
2.3
1.7
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
21
106
2.01
2.27
4.1
3.0
nmol/l
0.8
0.9
0.33
15
83
(3033705) Calcium.ionized [Moles/volume] in Venous blood
17
79
2.18
2.26
3.5
2.7
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
622
5911
1.35
2.22
29.3
16.2
mmol/l
138.9
139.6
6.94
605
5736
(3029937) Albumin [Presence] in Urine by Test strip
186
1537
1.28
2.20
5.6
3.8
estimate
0.0
0.0
0.88
72
534
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
11
42
2.64
2.19
1.0
1.2
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
8
24
3.36
2.18
1.0
1.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
22
115
1.94
2.17
1.4
1.6
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
22
115
1.94
2.17
3.9
3.0
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
19
94
2.05
2.17
5.7
3.0
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
257
2213
1.25
2.14
5.6
3.7
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
17
81
2.12
2.14
3.5
2.7
mmol/l
4.1
4.1
0.11
17
81
(3035285) Chloride [Moles/volume] in Venous blood
17
81
2.12
2.14
3.5
2.7
mmol/l
106.5
105.5
0.43
17
81
(3000494) Fungus identified in Specimen by Culture
93
698
1.38
2.14
1.5
1.4
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
5
10
5.03
2.07
1.0
1.0
—
—
—
0
0
(3019060) Gas panel - Arterial blood
55
377
1.50
2.06
6.3
5.8
—
—
—
0
0
(44790047)
15
69
2.20
2.05
1.7
1.5
—
—
—
0
0
(44790049)
15
69
2.20
2.05
1.7
1.5
—
—
—
0
0
(44790048)
15
69
2.20
2.05
1.7
1.5
—
—
—
0
0
(44806118)
15
69
2.20
2.05
1.7
1.5
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
622
5928
1.33
2.04
29.2
16.3
mmol/l
4.0
4.0
0.58
603
5741
(3024932) HLA-DR beta [Type]
6
15
4.02
2.04
1.2
1.1
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
17
83
2.07
2.02
1.0
1.1
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
8
26
3.10
2.02
1.6
1.7
iu/ml
—
1224630.0
—
0
5
(3048689) Calprotectin [Mass/mass] in Stool
96
732
1.36
2.01
2.4
2.3
ug/g
175.2
127.7
0.31
82
580
(3000093) Morphology [Interpretation] in Blood Narrative
12
51
2.38
1.96
1.3
1.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
157
1289
1.28
1.94
4.6
3.6
—
—
—
0
0
(3022145) Colonoscopy Study observation
82
613
1.38
1.94
1.3
1.3
—
—
—
0
0
(3024471) HLA-A [Type]
6
16
3.77
1.94
1.0
1.0
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
27
158
1.74
1.91
1.3
1.2
—
89.2
—
0
12
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
7
22
3.20
1.88
1.7
1.8
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
7
22
3.20
1.88
1.7
1.8
—
—
—
0
0
(3011648) Oxygen content in Venous blood
11
46
2.41
1.86
10.8
8.2
%
12.2
11.1
0.34
11
46
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
556
5245
1.25
1.83
5.3
4.6
mu/l
1.8
2.1
0.69
511
4779
(3019150) Specific gravity of Urine by Refractometry
152
1252
1.27
1.83
6.1
3.9
kg/l
1.0
1.0
0.04
29
175
(40757373) Influenza virus identified in Isolate
5
12
4.19
1.82
1.4
1.6
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
9
35
2.59
1.80
1.2
1.6
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
7
168
0.41
1.80
1.3
1.5
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
7
23
3.06
1.80
2.6
1.7
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
42
281
1.52
1.78
2.5
2.4
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
60
432
1.42
1.77
1.2
1.2
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
6
18
3.35
1.75
1.0
1.1
—
—
—
0
0
(4268621)
13
61
2.15
1.72
2.1
2.3
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
13
61
2.15
1.72
3.2
3.8
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
188
1602
1.23
1.68
4.9
3.2
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
12
55
2.20
1.68
5.0
2.5
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
198
1698
1.23
1.67
4.6
4.0
mg/mmol
11.3
10.1
0.15
137
1087
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
8
31
2.60
1.66
1.3
1.1
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
5
14
3.59
1.62
1.0
1.0
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
153
1281
1.25
1.60
7.1
4.6
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
13
63
2.08
1.60
1.7
1.3
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
8
32
2.52
1.60
2.9
2.3
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
7
156
0.44
1.56
1.1
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
7
156
0.44
1.56
1.1
1.4
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
86
672
1.32
1.56
12.7
7.1
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
14
71
1.99
1.54
1.1
1.4
—
—
—
0
0
(3004451) EKG impression Narrative
7
27
2.61
1.51
1.7
1.3
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
5
125
0.40
1.51
1.2
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
5
126
0.39
1.51
1.2
1.4
—
—
—
0
0
(3013512) EKG study
189
1629
1.22
1.51
4.6
3.8
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
88
694
1.30
1.50
4.3
4.4
%
32.1
31.7
0.10
63
462
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
115
939
1.27
1.50
1.3
1.3
iu/ml
35.8
35.1
0.02
30
296
(3043238) Trisomy 21 risk [Likelihood] in Fetus
5
129
0.38
1.49
1.2
1.5
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
14
72
1.96
1.49
1.1
1.2
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
13
65
2.02
1.49
1.8
1.4
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
551
5761
0.82
1.46
4.9
4.7
mmol/l
2.6
2.7
1.81
496
5289
(3006653) Thiamine [Moles/volume] in Blood
7
28
2.51
1.45
1.0
1.1
nmol/l
161.4
150.0
—
7
28
(3008757) Leukocyte morphology finding [Identifier] in Blood
13
66
1.99
1.44
5.2
4.0
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
5
16
3.14
1.44
1.2
1.3
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
5
16
3.14
1.44
1.0
1.1
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
7
155
0.45
1.44
1.1
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
7
155
0.45
1.44
1.1
1.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
408
3782
1.18
1.41
3.3
3.2
—
—
—
0
0
(3044889) 12 lead EKG panel
424
3947
1.18
1.38
4.2
3.8
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
16
89
1.82
1.38
1.4
1.4
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
17
283
0.59
1.34
1.4
1.5
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
42
301
1.42
1.32
10.8
11.4
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
30
201
1.51
1.32
2.3
2.4
u/l
182.9
3314.1
—
8
84
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
27
177
1.55
1.30
3.7
2.6
g/l
3.9
3.5
0.52
27
169
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
108
891
1.25
1.30
1.3
1.3
u/ml
12.1
10.9
0.06
40
353
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
14
76
1.86
1.30
1.4
1.5
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
5
18
2.79
1.28
2.0
1.6
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
538
5617
0.84
1.27
4.4
4.2
mmol/l
1.4
1.4
5.33
483
5164
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
56
425
1.34
1.27
2.9
2.5
ml/min/173m2
79.3
66.7
0.98
21
170
(3025468) Yersinia sp identified in Specimen by Organism specific culture
14
77
1.83
1.26
1.5
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
14
77
1.83
1.26
1.5
1.5
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
19
115
1.67
1.26
1.4
1.2
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
23
147
1.58
1.24
1.8
2.6
ug/min
72.7
93.4
0.13
12
89
(3005988) Vibrio sp identified in Specimen by Organism specific culture
14
78
1.81
1.21
1.5
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
14
78
1.81
1.21
1.5
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
14
78
1.81
1.21
1.5
1.5
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
561
5378
1.19
1.16
21.9
12.9
ml/min/173m2
82.9
82.0
0.37
492
4393
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
5
20
2.51
1.15
3.2
1.5
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
7
31
2.27
1.10
1.3
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
7
31
2.27
1.10
1.3
1.4
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
12
66
1.83
1.09
1.1
1.2
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
5
21
2.39
1.09
8.2
3.4
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
5
21
2.39
1.09
8.2
3.4
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
10
52
1.94
1.06
1.3
1.2
titre
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
7
33
2.13
1.05
1.3
1.4
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
7
33
2.13
1.05
1.3
1.4
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
149
1300
1.18
1.04
1.3
1.3
u/ml
3.6
1.2
0.45
32
351
(3045414) Leukocytes [Presence] in Urine
31
225
1.39
0.96
2.4
1.8
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
556
5356
1.16
0.95
23.6
15.0
%
38.7
40.1
2.72
377
3919
(21494755) Public health laboratory ask at order entry panel
45
575
0.77
0.94
1.2
1.4
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
546
5653
0.86
0.94
4.4
4.3
mmol/l
4.5
4.6
1.74
494
5227
(40761511) CBC panel - Blood by Automated count
624
6070
1.19
0.92
22.4
13.0
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
10
55
1.83
0.92
1.1
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
46
359
1.30
0.91
4.6
2.8
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
40
306
1.32
0.91
1.7
1.8
—
—
—
0
0
(3000492) Spirometry study
68
560
1.24
0.88
1.3
1.4
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
8
43
1.87
0.87
1.4
1.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
8
43
1.87
0.87
1.4
1.1
—
—
—
0
0
(3017704) Immunofixation for Urine
6
30
2.01
0.87
1.2
1.5
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
22
154
1.44
0.84
5.8
4.5
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
26
189
1.39
0.82
1.2
1.2
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
240
2209
1.13
0.81
2.3
2.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
26
190
1.38
0.80
1.2
1.2
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
6
33
1.82
0.79
9.7
3.5
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
25
0.00
0.79
0.0
1.2
—
6.8
—
0
25
(42529406) Shigella sp [Presence] in Stool by Culture
26
191
1.37
0.78
1.2
1.2
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
38
297
1.29
0.77
1.0
1.0
—
—
—
0
0
(21494434) Karyotype in Bone marrow
9
53
1.71
0.75
1.1
1.1
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
5
24
2.09
0.74
2.2
2.6
u/l
178.8
208.2
—
5
24
(3019897) Erythrocyte distribution width [Ratio] by Automated count
9
56
1.61
0.72
6.2
2.1
%
13.2
13.1
—
9
56
(3012441) Differential panel - Pleural fluid
10
60
1.68
0.72
1.6
1.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
120
1064
1.15
0.71
1.5
1.5
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
5
26
1.93
0.70
1.0
1.0
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
15
101
1.50
0.70
1.0
1.5
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
7
41
1.71
0.70
1.0
1.2
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
35
277
1.28
0.66
5.3
3.5
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
5
28
1.79
0.66
3.6
6.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
17
232
0.73
0.60
1.1
1.1
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
21
0.00
0.60
0.0
5.8
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
21
0.00
0.60
0.0
2.9
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
22
0.00
0.59
0.0
1.1
—
8.8
—
0
22
(3015183) Erythrocyte sedimentation rate
6
35
1.72
0.57
1.0
1.3
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
6
35
1.72
0.57
1.8
1.5
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
8
54
1.49
0.57
1.3
1.1
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
10
65
1.55
0.55
2.1
1.6
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
6
37
1.63
0.55
2.2
2.0
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
54
631
0.84
0.55
1.5
1.7
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
23
177
1.31
0.55
1.4
1.3
u/l
8.5
9.3
0.12
18
140
(3003327) Ova and parasites identified in Stool by Light microscopy
24
186
1.30
0.55
1.5
1.6
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
39
322
1.22
0.54
3.9
2.9
e6/l
0.4
0.2
0.54
39
312
(3005570) Glucose [Moles/volume] in Urine
9
60
1.51
0.54
1.7
2.3
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
531
5446
0.91
0.54
4.0
3.8
mmol/l
1.4
1.3
2.15
473
4986
(3023419) Bacteria identified in Sputum by Culture
11
74
1.49
0.53
3.8
2.7
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
15
108
1.40
0.53
1.7
1.8
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
629
6180
1.13
0.52
14.7
10.0
u/l
26.9
26.6
0.15
606
5960
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
11
75
1.47
0.51
4.7
1.7
pg
34.0
33.2
0.23
11
75
(3045788) Cell count panel - Pleural fluid
7
45
1.56
0.49
1.7
1.4
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
12
85
1.42
0.47
2.8
2.8
u/ml
18.1
52.2
0.32
12
80
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
23
182
1.27
0.47
1.2
1.4
miu/ml
227.3
255.1
0.13
12
90
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
12
165
0.72
0.47
1.1
1.4
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
22
274
0.80
0.44
1.5
1.6
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
74
825
0.89
0.43
1.5
1.4
—
—
—
0
0
(3000012) Reticulocyte production index
5
31
1.62
0.43
2.2
1.9
—
—
—
0
0
(3003338) MCHC [Mass/volume]
485
4971
0.93
0.42
29.7
18.0
g/l
332.5
332.8
0.30
474
4937
(3004616) Nuclear Ab [Presence] in Serum
8
58
1.38
0.41
1.3
1.2
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
16
0.00
0.41
0.0
1.0
—
21.9
—
0
16
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
8
59
1.36
0.41
1.1
1.2
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
3.9
—
—
—
0
0
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
0
18
0.00
0.40
0.0
1.3
—
0.5
—
0
12
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
13
97
1.35
0.39
1.0
1.2
u/ml
0.1
2.1
—
7
40
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
5
35
1.43
0.39
1.0
1.1
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
5
35
1.43
0.39
2.2
3.5
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
18
142
1.27
0.39
1.8
1.7
iu/l
3.7
6.5
—
5
44
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
5
36
1.39
0.38
1.2
1.2
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
5
36
1.39
0.38
1.4
1.3
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
8
115
0.69
0.37
2.1
1.7
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
5
37
1.35
0.37
2.2
3.3
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
27
226
1.20
0.36
1.4
1.3
iu/l
21.9
22.6
0.04
20
182
(3002256) Pathology report gross observation
78
709
1.11
0.36
1.2
1.3
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
9
71
1.27
0.36
1.9
1.8
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
22
266
0.82
0.35
3.9
2.8
u/ml
21.3
42.1
1.26
22
255
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
146
1553
0.93
0.35
4.1
4.2
%
21.1
21.5
0.10
71
719
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
71
647
1.11
0.32
2.1
2.0
—
—
—
0
0
(4034850)
21
175
1.21
0.30
12.4
10.2
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
12
93
1.30
0.30
1.1
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
12
93
1.30
0.30
1.1
1.1
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
7
55
1.28
0.30
1.9
2.1
—
1.7
—
0
6
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
105
1122
0.93
0.29
3.7
2.9
ug/l
0.7
0.8
0.77
79
722
(4146454)
7
57
1.23
0.29
3.6
2.9
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
20
237
0.84
0.28
4.8
1.8
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
64
586
1.10
0.28
1.4
1.4
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
20
168
1.20
0.27
1.5
1.4
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
77
713
1.09
0.27
2.4
2.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
43
388
1.12
0.25
1.8
1.9
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
497
4890
1.05
0.24
27.9
17.2
%
13.8
13.7
1.44
487
4792
(3049717) Cytology report of Urine Cyto stain
20
232
0.86
0.23
2.0
2.5
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
5
41
1.22
0.22
1.2
1.3
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3042552) Rheumatoid factor [Units/volume] in Pleural fluid
0
10
0.00
0.21
0.0
1.0
—
9.0
—
0
5
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
12
0.00
0.21
0.0
2.3
—
6425.7
—
0
12
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
11
134
0.82
0.20
1.6
1.5
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
6
51
1.18
0.19
1.0
1.2
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
6
51
1.18
0.19
2.0
1.5
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
646
6505
0.94
0.18
35.4
20.5
g/l
133.1
135.9
4.98
632
6402
(3023511) Choriogonadotropin [Units/volume] in Urine
15
128
1.18
0.18
1.7
1.3
—
—
—
0
0
(4010399)
43
397
1.09
0.17
1.3
1.4
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
646
6503
0.94
0.17
35.2
20.4
e9/l
7.2
6.8
4.88
627
6317
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
548
5536
0.96
0.17
4.7
4.4
mmol/l
6.2
5.9
2.43
489
5029
(3026361) Erythrocytes [#/volume] in Blood
646
6502
0.94
0.17
35.2
20.4
e12/l
4.4
4.5
3.82
626
6319
(3013139) Helicobacter pylori Ag [Presence] in Stool
37
340
1.09
0.17
1.2
1.2
—
—
—
0
0
(3035941) MCH [Entitic mass]
646
6501
0.95
0.16
35.1
20.3
pg
30.2
30.3
0.06
632
6401
(1002224) Polysomnography panel
21
235
0.89
0.16
1.1
1.1
—
—
—
0
0
(3024731) MCV [Entitic volume]
646
6500
0.95
0.16
35.1
20.3
fl
90.9
90.8
0.18
632
6400
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
9
79
1.14
0.15
1.4
1.6
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
646
6497
0.95
0.14
35.2
20.4
e9/l
254.0
248.5
1.14
629
6327
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
61
578
1.06
0.14
3.4
4.4
ug/l
4.1
30.5
1.19
51
489
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
8
100
0.80
0.13
1.4
1.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
23
210
1.10
0.12
1.4
1.7
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
10
116
0.86
0.12
4.0
2.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
10
86
1.17
0.11
1.2
1.2
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
19
173
1.10
0.10
4.6
8.8
mmol/l
1.2
1.3
0.06
14
150
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
21
193
1.09
0.10
1.5
1.8
nmol/l
47.1
38.5
0.76
21
182
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
12
135
0.89
0.10
1.3
1.3
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
5
48
1.04
0.09
1.0
1.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
152
1488
1.03
0.09
1.6
1.7
mmol/l
1.4
1.4
0.20
128
1247
(3032773) Endomysium IgG Ab [Titer] in Serum
6
54
1.11
0.09
1.0
1.0
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
6
56
1.07
0.08
2.5
1.7
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
522
5252
0.98
0.08
6.6
5.6
mmol/mol
42.0
39.8
3.96
479
4890
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
7
65
1.08
0.08
1.3
2.8
nmol/l
3.8
5.9
—
7
65
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
8
76
1.05
0.07
1.1
1.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
166
1635
1.02
0.06
1.5
1.5
—
—
—
0
0
(40768793) Breast Pathology biopsy report
14
129
1.09
0.05
1.3
1.3
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
10
90
1.11
0.05
1.0
1.1
—
—
—
0
0
(4094501)
14
151
0.93
0.05
1.3
1.1
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
18
190
0.95
0.04
1.4
1.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
33
320
1.03
0.03
1.2
1.3
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
38
390
0.97
0.03
1.2
1.2
iu/ml
89.1
159.5
1.08
11
150
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
193
1939
0.99
0.01
4.9
4.8
ug/l
2.6
2.6
0.05
177
1728
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
16
154
1.04
0.00
1.6
1.7
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
11
109
1.01
0.00
1.0
1.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
23
229
1.00
0.00
1.3
1.2
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
8
0.00
0.00
0.0
1.0
—
18.3
—
0
8
(3001729) Color of Synovial fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
48.7
—
0
6
(3002621) Streptococcal DNAse B [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
11.6
—
0
5
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
6
0.00
0.00
0.0
1.0
—
0.8
—
0
6
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
3.5
—
77.5
—
0
8
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
8
88
0.91
0.00
1.1
1.2
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
9
91
0.99
0.00
1.1
1.4
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
9
0.00
0.00
0.0
1.2
—
2.1
—
0
9
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
6
60
1.00
0.00
1.2
1.3
u/l
42.3
63.5
—
6
44
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758358) Immune stain study
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint AB1_VIRAL_ENCEPHALITIS_NOS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| AB1_VIRAL_ENCEPHALITIS_NOS | 2.464 [2.09, 2.9] | < 0.001 |
| Birth year | 0.992 [0.98, 1.0] | 0.08 |
During the follow-up period (1.1.1998 — 31.12.2019), 682 out of 2632 females with AB1_VIRAL_ENCEPHALITIS_NOS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| AB1_VIRAL_ENCEPHALITIS_NOS | 2.368 [2.0, 2.8] | < 0.001 |
| Birth year | 0.989 [0.98, 1.0] | 0.027 |
During the follow-up period (1.1.1998 — 31.12.2019), 697 out of 2910 males with AB1_VIRAL_ENCEPHALITIS_NOS died.
Mortality risk
Mortality risk for people of age
years, who have AB1_VIRAL_ENCEPHALITIS_NOS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.192% | 0.38% |
| 5 | 1.417% | 2.691% |
| 10 | 3.442% | 7.213% |
| 15 | 6.084% | 13.363% |
| 20 | 10.659% | 21.966% |
Relationships between endpoints
↥Index endpoint: AB1_VIRAL_ENCEPHALITIS_NOS – Viral encephalitis, not elsewhere classified/unspecified
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data